Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medios AG
Berlin, Germanymedios.ag ↗
- Ownership
- Public · ILM1
- Employees
- ~952
- Development stage
- Commercial
01
Overview
Medios is the leading provider of Specialty Pharma in Germany with approximately €1.8 billion in revenue in 2023. The company operates 6 GMP facilities, 4 distribution sites, and a blistering center, making it the largest pharmaceutical supplier and compounder of patient-specific therapies in Germany.
- Therapeutic areas
- OncologyImmunologyHematologyOphthalmologyNeurologyInfectious Diseases
- Modalities
- Patient-specific therapiesCytostatic infusion preparationsAntibody therapiesVirostatic medicationsAntibiotic medicationsParenteral nutrition solutionsInvestigational medicinal products
- Industry
- Contract Manufacturing Organization
02
Partnerships
700+ medical specialists850+ pharmaciesPharmaceutical companies
03
Financials
- Market cap
- $323.8M
- Total revenue
- $2.3B
- Enterprise value
- $454.3M
Beyond the preview
Go deeper on Medios AG.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Medios AG.